Scott North

Progression-free survival as a clinical trial endpoint in advanced renal cell carcinoma.

F. Saad, A. Kapoor, S. Hotte, 2011, Current oncology.

A phase II study of the HDAC inhibitor SB939 in patients with castration resistant prostate cancer: NCIC clinical trials group study IND195

E. Eisenhauer, J. Squire, S. Sridhar, 2015, Investigational New Drugs.

The effect of cisplatin-based neoadjuvant chemotherapy on the renal function of patients undergoing radical cystectomy.

Y. Lotan, C. Dinney, S. Daneshmand, 2023, Canadian Urological Association journal = Journal de l'Association des urologues du Canada.

A pilot study of the liposomal MUC1 vaccine BLP25 in prostate specific antigen failures after radical prostatectomy.

K. Graham, S. North, P. Venner, 2006, The Journal of urology.